Karyopharm Ahead of the Phase 3 Readout - A Volatility Trade with Binary Upside
Karyopharm (KPTI) is a commercial-stage oncology company trading near $5 with a market cap under $100M, elevated short interest (~21% of float) and stretched technicals. For traders who want a defined-risk way to play binary trial volatility, a disciplined long into the Phase 3 readout window offers asymmetric upside if the trial surprises positive…